Vassiliki Soubasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vassiliki Soubasi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Kosmas Sarafidis
1st Department of Neonatology and Neonatal Intensive Care, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Ippokrateion General Hospital, 54642 Thessaloniki, Greece
4 shared publications - Christos Theodoros Nakas
University of Thessaly
3 shared publications Konstantinos Mitsakis
2 shared publicationsMyrsini Griva
2 shared publicationsVassiliki Drossou
2 shared publicationsCh. Tsantali
Aristotle University of Thessaloniki
1 shared publication
Latest Publications
- Open Access
A New ABCA3 Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome
Mutations in adenosine triphosphate-binding cassette transporter A3 (ABCA3) (OMIM: 601615) gene constitute the most frequent genetic cause of severe neonatal respiratory distress syndrome (RDS) and interstitial lung disease (ILD) in children. Interstitial lung disease in children and especially in infants, in contrast to adults, is more likely to appear as a result of developmental deficits or is characterized by genetic aberrations of pulmonary surfactant homeostasis not responding to exogenous surfactant administration. The underlying ABCA3 gene mutations are commonly thought, regarding null mutations, to determine the clinical course of the disease while there exist mutation types, especially missense variants, whose effects on surfactant proteins are difficult to predict. In addition, clinical and radiological signs overlap with those of surfactant proteins B and C mutations making diagnosis challenging. We demonstrate a case of a one-term newborn male with lethal respiratory failure caused by homozygous missense ABCA3 gene mutation c.3445G>A (p.Asp1149Asn), which, to our knowledge, was not previously reported as a causative agent of newborn lethal RDS. Therapeutic strategies for patients with ABCA3 gene mutations are not sufficiently evidence-based. Therefore, the description of the clinical course and treatment of the disease in terms of a likely correlation between genotype and phenotype is crucial for the development of the optimal clinical approach for affected individuals.
Open AccessA New ABCA3 Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome
Mutations in adenosine triphosphate-binding cassette transporter A3 (ABCA3) (OMIM: 601615) gene constitute the most frequent genetic cause of severe neonatal respiratory distress syndrome (RDS) and interstitial lung disease (ILD) in children. Interstitial lung disease in children and especially in infants, in contrast to adults, is more likely to appear as a result of developmental deficits or is characterized by genetic aberrations of pulmonary surfactant homeostasis not responding to exogenous surfactant administration. The underlying ABCA3 gene mutations are commonly thought, regarding null mutations, to determine the clinical course of the disease while there exist mutation types, especially missense variants, whose effects on surfactant proteins are difficult to predict. In addition, clinical and radiological signs overlap with those of surfactant proteins B and C mutations making diagnosis challenging. We demonstrate a case of a one-term newborn male with lethal respiratory failure caused by homozygous missense ABCA3 gene mutation c.3445G>A (p.Asp1149Asn), which, to our knowledge, was not previously reported as a causative agent of newborn lethal RDS. Therapeutic strategies for patients with ABCA3 gene mutations are not sufficiently evidence-based. Therefore, the description of the clinical course and treatment of the disease in terms of a likely correlation between genotype and phenotype is crucial for the development of the optimal clinical approach for affected individuals.
- 1 November 2012
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 16 (6) , 625-630
Early abnormal amplitude-integrated electroencephalography (aEEG) is associated with adverse short-term outcome in premature infants
- 1 November 2012
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 16 (6) , 625-630
Early abnormal amplitude-integrated electroencephalography (aEEG) is associated with adverse short-term outcome in premature infants
- 1 February 2010
- Published by Elsevier in Diabetes & Metabolism
- Vol. 36 (1) , 58-63
Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation
- 1 February 2010
- Published by Elsevier in Diabetes & Metabolism
- Vol. 36 (1) , 58-63
Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation
- 1 December 2009
- Published by Elsevier in Early Human Development
- Vol. 85 (12) , 761-765
The influence of extrauterine life on the aEEG maturation in normal preterm infants
- 1 December 2009
- Published by Elsevier in Early Human Development
- Vol. 85 (12) , 761-765
The influence of extrauterine life on the aEEG maturation in normal preterm infants
- 1 July 1994
- Published by Springer Nature in Pediatric Research
- Vol. 36 (1) , 38A
215 WHICH IS THE BEST TIMING OF EPO ADMINISTRATION IN ANEMIA OF PREMATU RITY (AOP): RANDOMIZED CONTROLLED STUDY
- 1 July 1994
- Published by Springer Nature in Pediatric Research
- Vol. 36 (1) , 38A
215 WHICH IS THE BEST TIMING OF EPO ADMINISTRATION IN ANEMIA OF PREMATU RITY (AOP): RANDOMIZED CONTROLLED STUDY